ctrl K

Watchlist Price Alert

TFF Pharmaceuticals Inc. (TFFP)

NASDAQ: TFFP · Real-Time Price · USD

0.07

-0.09 (-56.98%)

At close: Dec 12, 2024, 9:00 PM

TFF Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	733.87K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	502.48K	388.22K	111.45K	n/a	n/a	n/a	n/a	n/a
Gross Profit	231.39K	-388.22K	-111.45K	n/a	n/a	n/a	n/a	n/a
Operating Income	-21.89M	-31.8M	-31.79M	-18.69M	-11.99M	-3.9M	-178.6K	-370.37K
Interest Income	n/a	26.73K	51.23K	126.42K	117.33K	55.96K	n/a	n/a
Pretax Income	-21.24M	-31.77M	-31.04M	-18.57M	-11.87M	-3.84M	-178.6K	-370.37K
Net Income	-21.24M	-31.77M	-30.99M	-18.44M	-11.75M	-3.84M	-178.6K	-370.37K
Selling & General & Admin	10.57M	13.8M	10.57M	8.01M	3.17M	3.05M	178.6K	141.11K
Research & Development	11.56M	18.5M	21.3M	10.68M	8.82M	848.81K	n/a	229.26K
Other Expenses	n/a	-495.81K	-88.16K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	22.13M	31.8M	31.79M	18.69M	11.99M	3.9M	178.6K	370.37K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.63M	31.8M	31.79M	18.69M	11.99M	3.9M	178.6K	370.37K
Income Tax Expense	n/a	-26.73	-51.23K	-126.42K	-117.33K	n/a	-52.52K	n/a
Shares Outstanding (Basic)	1.79M	1.2M	992.84K	817.01K	276.2K	738.04K	17.83M	738.04K
Shares Outstanding (Diluted)	1.79M	1.2M	992.84K	817.01K	276.2K	738.04K	17.83M	738.04K
EPS (Basic)	-11.85	-26.49	-31.21	-22.57	-42.55	-5.21	-0.01	-0.5
EPS (Diluted)	-11.85	-26.49	-31.21	-22.57	-42.55	-5.21	-0.01	-0.5
EBITDA	-20.74M	-31.41M	-30.93M	-18.69M	-11.99M	-3.9M	-178.6K	-370.37K
EBIT	-21.24M	-31.77M	-31.04M	-18.57M	-11.87M	-3.84M	-178.6K	-370.37K
Depreciation & Amortization	502.48K	388.22K	111.45K	206.3K	171.86K	n/a	52.52K	n/a